Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.

NCT02501928 PHASE3 COMPLETED Results posted

The purpose of this study is to investigate the safety and tolerability of fesoterodine following once daily long-term treatment in Japanese pediatric neurogenic detrusor overactivity (NDO) subjects.

Details

Lead sponsor	Pfizer
Phase	PHASE3
Status	COMPLETED
Enrolment	12
Start date	Fri Jun 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Apr 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Urinary Bladder, Neurogenic

Interventions

• Fesoterodine PR 4 mg
• Fesoterodine PR 8 mg
• Fesoterodine BIC 2 mg
• Fesoterodine BIC 4 mg

Countries

Japan